RDHL
RedHill Biopharma Ltd.Company with tickers: RDHL
Market Cap
$43.80B
Shares Outstanding
50,923,261,000
CIK
1553846
CUSIP
757468301
13F Activity (30d)
2 filings
1 filers
Website
Visit website
Investor Relations
Investor relations
Earnings calls and other investor events (conferences, investor days) grouped as single events — the transcript and audio, plus, for earnings calls, the 8-K earnings release and the quarter's 10-Q or 10-K. Each badge shows which artefacts have landed.
| Period | Call date | Event | Artefacts | Open |
|---|---|---|---|---|
| Annual General Meeting | 2026-03-05 | Extraordinary General Meeting of Shareholders |
Audio
Transcript
Slides
|
|
| Annual General Meeting | 2025-05-05 | 2025 Annual General Meeting of Shareholders |
Audio
Transcript
Slides
|
|
| FY2022 Q1 | 2022-03-31 | RedHill Biopharma Ltd. Q1 FY2022 Earnings Call |
Audio
Transcript
Slides
8-K10-Q
|
|
| FY2021 Q4 | 2021-12-31 | RedHill Biopharma Ltd. Q4 FY2021 Earnings Call |
Audio
Transcript
Slides
8-K10-K
|
|
| FY2021 Q3 | 2021-09-30 | RedHill Biopharma Ltd. Q3 FY2021 Earnings Call |
Audio
Transcript
Slides
8-K10-Q
|
|
| FY2021 Q2 | 2021-06-30 | RedHill Biopharma Ltd. Q2 FY2021 Earnings Call |
Audio
Transcript
Slides
8-K10-Q
|
|
| FY2021 Q1 | 2021-03-31 | RedHill Biopharma Ltd. Q1 FY2021 Earnings Call |
Audio
Transcript
Slides
8-K10-Q
|
|
| FY2020 Q4 | 2020-12-31 | RedHill Biopharma Ltd. Q4 FY2020 Earnings Call |
Audio
Transcript
Slides
8-K10-K
|
|
| FY2020 Q3 | 2020-09-30 | RedHill Biopharma Ltd. Q3 FY2020 Earnings Call |
Audio
Transcript
Slides
8-K10-Q
|
|
| FY2020 Q2 | 2020-06-30 | RedHill Biopharma Ltd. Q2 FY2020 Earnings Call |
Audio
Transcript
Slides
8-K10-Q
|
|
| FY2020 Q1 | 2020-03-31 | RedHill Biopharma Ltd. Q1 FY2020 Earnings Call |
Audio
Transcript
Slides
8-K10-Q
|
Showing 1–11 of 11 earnings calls